Special Focuses

  1. Undertaking pivotal multicenter stroke clinical trials in Taiwan with the capability of validating the safety and efficacy of novel preventive and therapeutic drugs and devices derived from NRPB projects or developed by biotech companies in Taiwan and abroad.
  2. Initiating multicenter stroke clinical trials to validate preventive and therapeutic strategies originated by the Taiwan Stroke Registry members to confirm clinical relevance on findings derived from Taiwan Stroke Registry (TSR).
  3. To conduct multicenter stroke clinical trials to verify and validate the safety and efficacy of novel drugs and medical devices developed by investigators outside NRPB or TSR.
  4. To conduct multicenter stroke clinical trials to verify and validate the safety and efficacy of novel drugs and medical devices sponsored by domestic or foreign pharmaceutical or biotech companies.
  5. To conduct multicenter stroke clinical trials to verify and validate the clinical significance of stroke biomarkers identified by the Stroke Biosignature Project (SBP).
  6. To participate in international stroke clinical trials that are initiated by the TCTCS members, NRPB investigators, other stroke investigators outside NRPB or TSR or sponsored by government from other countries or pharmaceutical companies.